Clinical Trial Update: Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A dose-finding and safety study of an oral single-agent therapy for advanced solid tumors, including metastatic bladder cancer, completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Solid Tumor

Drugs mentioned

• Processa Pharmaceuticals

Snippet

Sponsor: Processa Pharmaceuticals | Conditions: Solid Tumor, Metastatic Bladder Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-06